Share on facebook Share on Twitter Share on Google Plus Share This
Back to Results

Rachel J. Buchsbaum, MD accepting new patients


Overview

Programs + Specialties
Training + Education Cornell University Medical College; Beth Israel Deaconess Medical Center; Tufts Medical Center
Board Certifications Hematology, Internal Medicine, Oncology
NPI # 1255360640
Gender Female
Accepted Insurances View Accepted Insurances at Tufts MC + Floating Hospital

Locations + Directions

Tufts Medical Center
South Building, 7th Floor
800 Washington St.
Box 245
Boston, MA 02111
Phone #: 617-636-5757
Fax #: 617-636-2342

Honors + Awards

2017 "Top Doctor", Boston Magazine
Milton O. and Natalie V. Zucker Clinical Teaching Prize for Innovation in Medical Education, Tufts University School of Medicine
Outstanding Lecturer, Tufts University School of Medicine
Faculty of 1000, Cell Signalling Section
Diane Connolly-Zaniboni Scholar in Breast Cancer Research
Top Doctor, US News and World Report
Castle Connolly, Exceptional Women in Medicine

News, Media + Videos

Research Focus

I became interested in cancer research during medical school and residency. During my early fellowship training in Hematology and Oncology I explored the biology of B and T lymphocytes and the role of cytotoxic T lymphocytes in murine models of EBV-associated lymphoproliferative disease. I subsequently became interested in using the molecular biology of signal transduction to investigate pathways underlying cancer cell invasion and metastasis. My laboratory joined the Molecular Oncology Research Institute in 2003 and transitioned to the Division of Hematology/Oncology in 2017. We are exploring the role of the tumor microenvironment in breast cancer biology, with a specific focus on how intra-cellular and inter-cellular signaling pathways are affected in the co-evolution of breast cancer and the breast cancer microenvironment. A major aim is translating our findings in the laboratory to the development of prognostic, predictive, and therapeutic tools for the treatment of patients with breast cancer.